Adverse events during the Scleroderma Lung Study |
| |
| Authors: | Furst Daniel E,Tseng Chi-Hong,Clements Philip J,Strange Charlie,Tashkin Donald P,Roth Michael D,Khanna Dinesh,Li Ning,Elashoff Robert,Schraufnagel Dean E Scleroderma Lung Study |
| |
| Affiliation: | aDavid Geffen School of Medicine, University of California Los Angeles, Los Angeles, Calif;bGeneral Internal Medicine Division, Department of Medicine, University of California Los Angeles, Los Angeles, Calif;cDepartment of Medicine, Medical University of South Carolina, Charleston;dDivision of Pulmonary and Critical Care Medicine David Geffen School of Medicine, University of California Los Angeles, Los Angeles, Calif;eBiostatistics and Bioinformatics, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, Calif;fDepartment of Biostatistics, University of California Los Angeles;gPulmonary, Critical Care, Sleep and Allergy Department of Medicine M/C 719 University of Illinois at Chicago |
| |
| Abstract: | |
| |
| Keywords: | Adverse events Cyclophosphamide Randomized controlled trial Systemic sclerosis |
| 本文献已被 ScienceDirect PubMed 等数据库收录！ |
|
